BREAKING
AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 12 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 2 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 2 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 2 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 5 days ago Zoom Communications Q4 2025 Earnings Results 6 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 6 days ago Synopsys Q1 2026 Earnings Results 6 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 6 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 6 days ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 12 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 2 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 2 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 2 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 5 days ago Zoom Communications Q4 2025 Earnings Results 6 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 6 days ago Synopsys Q1 2026 Earnings Results 6 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 6 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 6 days ago
ROIV

Roivant Sciences

$ROIV NASDAQ Feb 6, 2026 All Day

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

ROIV Coverage

Event Roivant Sciences (ROIV) Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna Mar 3, 2026 Event Roivant Sciences (ROIV) Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis Mar 3, 2026 Event Roivant Sciences (ROIV) Sec Form 8K Feb 7, 2026 News Roivant Reports Q3 Results, Cites Phase 2 Breakthrough and Catalyst-Rich 2026 Feb 6, 2026 News Roivant Sciences Reports Fiscal Third Quarter 2025 Results Amid Robust Pipeline Advancement Feb 6, 2026 Transcript Roivant Sciences (ROIV) Q3 2025 Earnings Call Transcript Jan 22, 2026 Transcript Roivant Sciences (ROIV) Q4 2025 Earnings Call Transcript Jan 22, 2026